Masimo Corporation shares rise 1.67% intraday as Apple Watch blood oxygen feature returns.

Masimo Corporation rose 1.67% intraday, with the company's legal battle with Apple Inc. (AAPL) over the blood oxygen tracking feature on Apple Watch coming to an end. Apple has agreed to restore the feature following a ruling by US Customs, which will benefit Apple Watch owners who bought models with the feature disabled. The restoration comes as part of iOS 18.6.1 and watchOS 11.6.1 software updates and includes a workaround that shows the data on an iPhone rather than the Apple Watch.